Long-term outcomes and recurrence-free interval after the treatment of keloids with a standardized protocol.

Abstract

BACKGROUND:

Recurrence rates of keloids have generally been reported at one time point. However, the longer the duration after treatment, the greater the likelihood that such lesions will recur. In this study, we analysed the time to recurrence during long-term follow-up.

MATERIAL AND METHODS:

We retrospectively reviewed recurrence-free interval in 52 patients with keloid (age 8-79 years) who had been treated between June 2006 and January 2011 using a standardised protocol developed by our group.

RESULTS:

Mean duration of follow-up was 37.5 (range, 7-120) months in patients with keloid. Kaplan-Meier survival curves revealed a statistically significant difference in recurrence-free interval between ear keloids and keloids excluding ear keloids. Recurrence rate for keloids was high in the first 2 years after treatment.

CONCLUSIONS:

Kaplan-Meier analysis was useful for understanding the tendency of recurrence of keloids after treatment using a standardised protocol.

• Authors: T Maeda, E Funayama, Y Yamamoto, N Murao, M Osawa, K Ishikawa, T Hayashi
• Journal: Journal of tissue viability (J Tissue Viability) Vol. 30 Issue 1 Pg. 128-132 (Feb 2021) ISSN: 0965-206X [Print] England
• PMID: 33288386 (Publication Type: Journal Article)
• Copyright: Copyright © 2020 Tissue Viability Society. Published by Elsevier Ltd. All rights reserved.

Chemical References

• Glucocorticoids
• Triamcinolone

Topics

• Adult
• Aftercare (methods, statistics & numerical data)
• Aged
• Child
• Clinical Protocols (standards)
• Female
• Glucocorticoids (pharmacology, therapeutic use)
• Humans
• Japan
• Kaplan-Meier Estimate
• Keloid (drug therapy, physiopathology)
• Long-Term Care (methods)
• Male
• Middle Aged
• Retrospective Studies
• Triamcinolone (pharmacology, therapeutic use)